Examine the characterization of biofilm formation and inhibition by targeting SrtA mechanism in Bacillus subtilis: a combined experimental and theoretical study

  • Chandrabose Selvaraj
  • Jeyachandran Sivakamavalli
  • Baskaralingam Vaseeharan
  • Poonam Singh
  • Sanjeev Kumar Singh
Original Paper

Abstract

Bacillus subtilis is one of the well-known biofilm-forming organisms associated with plants, animals, and also used as a model organism for all Bacillus sp. In B. subtilis, SrtA enzyme plays the imperative roles in mechanism of signaling pathway and microbial adherence toward the host. SrtA is highly considered as a universal drug target for all Gram positive pathogens. Because of unresolved 3D structure of SrtA in Gram positive bacteria including B. subtilis, we developed a homology model protein using structural alignments of similar SrtA from B. anthracis. While the structural model of SrtA is analyzed because of its significance in biofilm formation by screening the suitable active site based compounds and analyzing the ability of bacterial biofilm inhibition. Druggability site based screening able to retrieve the active compounds against SrtA and checked the activity of the screened compounds through experimental biochemical assays and in situ microscopic analysis. Here in this study we concluded the computationally screened SrtA inhibitors showed high level of biofilm inhibition despite difficulties in bacterial membrane rigidification. Hence this study leads a way to the new compounds that may be useful to treat the bacterial infections

Figure

Bacillus subtilis is one of the well-known biofilm-forming organisms referred to as model organism for all gram positive pathogens. From this organism, the universal drug target SrtA is evaluated for its biofilm forming ability and inhibitors are screened against the same, through in silico and in vitro methods. Druggability region based SrtA inhibitors are successful by showing anti microbial and anti biofilm activity. This study shows prominent common SrtA inhibitors against the gram positive pathogens

Keywords

Bacillus anthracis Bacillus subtilis CLSM Signaling mechanism SrtA Virtual screening 

Abbreviations

B. subtilis

Bacillus subtilis

B. anthracis

Bacillus anthracis

SrtA

Sortase A

MD simulation

Molecular dynamics simulation

CLSM

Confocal laser scanning microscopy

Notes

Acknowledgments

The authors thankfully acknowledge the CSIR for research funding and fellowship grants (Ref. No: 37(1491)/11/EMR-II). One of the authors Chandrabose Selvaraj gratefully acknowledges CSIR for the Senior Research Fellowship (SRF). JSV gratefully acknowledges the Council of Scientific and Industrial Research (CSIR), New Delhi for the financial assistance Rendered [Ref: 9/688 (0023)/2013, EMR-I]. Poonam Singh and Sanjeev Kumar Singh acknowledge CSIR-CDRI and Alagappa University for signing the Memorandum of Understanding.

Supplementary material

894_2014_2364_MOESM1_ESM.doc (445 kb)
ESM 1 (DOC 445 kb)

References

  1. 1.
    Gonzalez-Pastor JE, Hobbs EC, Losick R (2003) Cannibalism by sporulating bacteria. Science 301:510–513CrossRefGoogle Scholar
  2. 2.
    Hamoen LW, Venema G, Kuipers OP (2003) Controlling competence in Bacillus subtilis: shared use of regulators. Microbiology 149:9–17CrossRefGoogle Scholar
  3. 3.
    Dahl MK, Msadek T, Kunst F, Rapoport G (1992) The phosphorylation state of the DegU response regulator acts as a molecular switch allowing either degradative enzyme synthesis or expression of genetic competence in Bacillus subtilis. J Biol Chem 267:14509–14514Google Scholar
  4. 4.
    Branda SS, Gonzalez-Pastor JE, Ben-Yehuda S, Losick R, Kolter R (2001) Fruiting body formation by Bacillus subtilis. Proc Natl Acad Sci U S A 98:11621–11626CrossRefGoogle Scholar
  5. 5.
    Hamon MA, Lazazzera BA (2001) The sporulation transcription factor Spo0A is required for biofilm development in Bacillus subtilis. Mol Microbiol 42:1199–1209CrossRefGoogle Scholar
  6. 6.
    Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V et al (1997) The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature 390:249–256CrossRefGoogle Scholar
  7. 7.
    Wipat A, Harwood CR (1999) The Bacillus subtilis genome sequence: the molecular blueprint of a soil bacterium. FEMS Microbiol Ecol 28:1–9. doi: 10.1111/j.1574-6941.1999.tb00555.x CrossRefGoogle Scholar
  8. 8.
    Durrett R, Miras M, Mirouze N, Narechania A, Mandic-Mulec I, Dubnau D. (2013) Genome sequence of the Bacillus subtilis biofilm-forming transformable strain PS216. Genome Announc. 1Google Scholar
  9. 9.
    Stoodley P, Sauer K, Davies DG, Costerton JW (2002) Biofilms as complex differentiated communities. Annu Rev Microbiol 56:187–209CrossRefGoogle Scholar
  10. 10.
    Lopez D, Vlamakis H, Kolter R (2010) Biofilms. Cold Spring Harb Perspect Biol 2:a000398CrossRefGoogle Scholar
  11. 11.
    Kolter R, Greenberg EP (2006) Microbial sciences: the superficial life of microbes. Nature 441:300–302CrossRefGoogle Scholar
  12. 12.
    Kline KA, Kau AL, Chen SL, Lim A, Pinkner JS, Rosch J et al (2009) Mechanism for sortase localization and the role of sortase localization in efficient pilus assembly in Enterococcus faecalis. J Bacteriol 191:3237–3247CrossRefGoogle Scholar
  13. 13.
    Bryers JD (2008) Medical biofilms. Biotech bioeng 100:1–18CrossRefGoogle Scholar
  14. 14.
    O’toole JE, Tuttle J R, Tuttle M E, Lowrey T, Devereaux KM, Pax G E, Rotzoll RR. (2000) U.S. Patent No. 6,130,602. Washington, DC: U.S. Patent and Trademark Office.Google Scholar
  15. 15.
    Mazmanian SK, Liu G, Ton-That H, Schneewind O (1999) Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 285:760–763CrossRefGoogle Scholar
  16. 16.
    Marraffini LA, Dedent AC, Schneewind O (2006) Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria. Microbiol Mol Biol Rev 70:192–221CrossRefGoogle Scholar
  17. 17.
    Nagórska K, Bikowski M, Obuchowski M (2007) Multicellular behaviour and production of a wide variety of toxic substances support usage of Bacillus subtilis as a powerful biocontrol agent. Acta Biochem Polo- Eng Ed 54:495Google Scholar
  18. 18.
    Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322CrossRefGoogle Scholar
  19. 19.
    Karatan E, Watnick P. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mole Biol Rev. 73: 310-347.Google Scholar
  20. 20.
    Romero D, Vlamakis H, Losick R, Kolter R (2011) An accessory protein required for anchoring and assembly of amyloid fibres in B. subtilis biofilms. Mole microbiol 80:1155–1168CrossRefGoogle Scholar
  21. 21.
    Lee VT, Schneewind O (2001) Protein secretion and the pathogenesis of bacterial infections. Genes Dev 15:1725–1752CrossRefGoogle Scholar
  22. 22.
    Anderson TD, Robson SA, Jiang XW, Malmirchegini GR, Fierobe HP, Lazazzera BA et al (2011) Assembly of minicellulosomes on the surface of Bacillus subtilis. Appl Environ Microbiol 77:4849–4858CrossRefGoogle Scholar
  23. 23.
    Maresso AW, Schneewind O (2008) Sortase as a target of anti-infective therapy. Pharmacol Rev 60:128–141CrossRefGoogle Scholar
  24. 24.
    Levesque CM, Voronejskaia E, Huang YC, Mair RW, Ellen RP, Cvitkovitch DG (2005) Involvement of sortase anchoring of cell wall proteins in biofilm formation by Streptococcus mutans. Infect Immun 73:3773–3777CrossRefGoogle Scholar
  25. 25.
    Weiner EM, Robson S, Marohn M, Clubb RT. The Sortase A enzyme that attaches proteins to the cell wall of Bacillus anthracis contains an unusual active site architecture. J Biol Chem. 285: 23433-43.Google Scholar
  26. 26.
    Suree N, Liew CK, Villareal VA, Thieu W, Fadeev EA, Clemens JJ et al (2009) The structure of the Staphylococcus aureus sortase-substrate complex reveals how the universally conserved LPXTG sorting signal is recognized. J Biol Chem 284:24465–24477CrossRefGoogle Scholar
  27. 27.
    Race PR, Bentley ML, Melvin JA, Crow A, Hughes RK, Smith WD et al (2009) Crystal structure of Streptococcus pyogenes sortase A: implications for sortase mechanism. J Biol Chem 284:6924–6933CrossRefGoogle Scholar
  28. 28.
    Hendrickx AP, Budzik JM, Oh SY, Schneewind O (2011) Architects at the bacterial surface - sortases and the assembly of pili with isopeptide bonds. Nat Rev Microbiol 9:166–176CrossRefGoogle Scholar
  29. 29.
    Pronk S, Pall S, Schulz R, Larsson P, Bjelkmar P, Apostolov R et al (2013) GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29:845–854CrossRefGoogle Scholar
  30. 30.
    Mount DW. (2007) Using the Basic Local Alignment Search Tool (BLAST). CSH Protoc. pdb top17.Google Scholar
  31. 31.
    Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680CrossRefGoogle Scholar
  32. 32.
    Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, et al. (2007) Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci. Chapter 2: Unit 2 9.Google Scholar
  33. 33.
    Shafreen RM, Selvaraj C, Singh SK, Pandian SK (2013) Exploration of fluoroquinolone resistance in Streptococcus pyogenes: comparative structure analysis of wild-type and mutant DNA gyrase. J Mol Recognit 26:276–285CrossRefGoogle Scholar
  34. 34.
    Thangapandian S, John S, Arooj M, Lee KW (2012) Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design. PLoS ONE 7:e34593CrossRefGoogle Scholar
  35. 35.
    Patschull AO, Gooptu B, Ashford P, Daviter T, Nobeli I (2013) In silico assessment of potential druggable pockets on the surface of alpha1-antitrypsin conformers. PLoS ONE 7:e36612CrossRefGoogle Scholar
  36. 36.
    Tripathi SK, Singh SK, Singh P, Chellaperumal P, Reddy KK, Selvaraj C (2012) Exploring the selectivity of a ligand complex with CDK2/CDK1: a molecular dynamics simulation approach. J Mol Recognit 25:504–512CrossRefGoogle Scholar
  37. 37.
    Selvaraj C, Singh SK. Validation of potential inhibitors for SrtA against Bacillus anthracis by combined approach of ligand-based and molecular dynamics simulation. J Biomol Struct Dyn. DOI:10.1080/07391102.2013.818577.Google Scholar
  38. 38.
    Sherman W, Beard HS, Farid R (2006) Use of an induced fit receptor structure in virtual screening. Chem Biol Drug Des 67:83–84CrossRefGoogle Scholar
  39. 39.
    Barreca ML, Iraci N, De Luca L, Chimirri A (2009) Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors. ChemMedChem 4:1446–1456CrossRefGoogle Scholar
  40. 40.
    Selvaraj C, Singh SK, Tripathi SK, Reddy KK, Rama M (2012) In silico screening of indinavir-based compounds targeting proteolytic activity in HIV PR: binding pocket fit approach. Med Chem Res 21:4060–4068CrossRefGoogle Scholar
  41. 41.
    Das D, Koh Y, Tojo Y, Ghosh AK, Mitsuya H (2009) Prediction of potency of protease inhibitors using free energy simulations with polarizable quantum mechanics-based ligand charges and a hybrid water model. J Chem Inf Model 49:2851–2862CrossRefGoogle Scholar
  42. 42.
    You J, Xue X, Cao L, Lu X, Wang J, Zhang L et al (2007) Inhibition of Vibrio biofilm formation by a marine actinomycete strain A66. Appl Microbiol Biotechnol 76:1137–1144CrossRefGoogle Scholar
  43. 43.
    Baldassarri L, Creti R, Recchia S, Imperi M, Facinelli B, Giovanetti E et al (2006) Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J Clin Microbiol 44:2721–2727CrossRefGoogle Scholar
  44. 44.
    Hell E, Giske CG, Nelson A, Romling U, Marchini G (2010) Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Lett Appl Microbiol 50:211–215CrossRefGoogle Scholar
  45. 45.
    Johansson EM, Crusz SA, Kolomiets E, Buts L, Kadam RU, Cacciarini M et al (2008) Inhibition and dispersion of Pseudomonas aeruginosa biofilms by glycopeptide dendrimers targeting the fucose-specific lectin LecB. Chem Biol 15:1249–1257CrossRefGoogle Scholar
  46. 46.
    Favre-Bonte S, Kohler T, Van Delden C (2003) Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. J Antimicrob Chemother 52:598–604CrossRefGoogle Scholar
  47. 47.
    Sandasi M, Leonard CM, Viljoen AM (2009) The in vitro antibiofilm activity of selected culinary herbs and medicinal plants against Listeria monocytogenes. Lett Appl Microbiol 50:30–35CrossRefGoogle Scholar
  48. 48.
    Ramage G, Bachmann S, Patterson TF, Wickes BL, Lopez-Ribot JL (2002) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49:973–980CrossRefGoogle Scholar
  49. 49.
    Shafreen RM, Srinivasan S, Manisankar P, Pandian SK (2012) Biofilm formation by Streptococcus pyogenes: modulation of exopolysaccharide by fluoroquinolone derivatives. J Biosci Bioeng 112:345–350CrossRefGoogle Scholar
  50. 50.
    Aguilar C, Vlamakis H, Losick R, Kolter R (2007) Thinking about Bacillus subtilis as a multicellular organism. Curr opi microbial 10:638–643CrossRefGoogle Scholar
  51. 51.
    Branda SS, Chu F, Kearns DB, Losick R, Kolter R (2006) A major protein component of the Bacillus subtilis biofilm matrix. Mol microbial 59:1229–1238CrossRefGoogle Scholar
  52. 52.
    Kolodkin-Gal I, Cao S, Chai L, Böttcher T, Kolter R, Clardy J, Losick R (2012) A self-produced trigger for biofilm disassembly that targets exopolysaccharide. Cell 149:684–692CrossRefGoogle Scholar
  53. 53.
    Zhang J, Burrows S, Gleason C, Matthews MA, Drews MJ, LaBerge M, An YH (2006) Sterilizing Bacillus pumilus spores using supercritical carbon dioxide. J Microbiol Methods 66:479CrossRefGoogle Scholar
  54. 54.
    Ahmed SF, Klena J, Husain T, Monestersky J, Naguib A, Wasfy MO (2013) Genetic characterization of antimicrobial resistance of Shigella flexneri isolates from patients in Egypt and Pakistan. Ann Clin Microbiol Antimicrob 12:9CrossRefGoogle Scholar
  55. 55.
    Boyanova L, Gergova G, Nikolov R, Derejian S, Lazarova E, Katsarov N, Krastev Z (2005) Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods. J Med Microbiol 54:481–483CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Chandrabose Selvaraj
    • 1
  • Jeyachandran Sivakamavalli
    • 2
  • Baskaralingam Vaseeharan
    • 2
  • Poonam Singh
    • 3
  • Sanjeev Kumar Singh
    • 1
  1. 1.Computer Aided Drug Design and Molecular Modeling Lab, Department of BioinformaticsAlagappa UniversityKaraikudiIndia
  2. 2.Crustacean Molecular Biology & Genomics Lab, Department of Animal Health and ManagementAlagappa UniversityKaraikudiIndia
  3. 3.Toxicology DivisionCentral Drug Research InstituteLucknowIndia

Personalised recommendations